Blood Plasma Products Market: By Product Type, Immunoglobulin, Protease inhibitors, Others), By Application, By End User and Region Forecast 2019-2030

Blood Plasma Products Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Albumin, Fresh Frozen Plasma (FFP), Immunoglobulin, Protease inhibitors, Others), By Application (Hematology, Hemato-oncology, Immunology, Rheumatology, Others), By End User (Hospitals, Clinical research laboratories, Others) and Region Forecast 2019-2030

Blood Plasma Products Market size was valued at US$ x million in 2023 and is expected to grow at a significant CAGR of 9% from 2024-2030. Blood plasma products are the liquid components of the blood that are extracted using a process called fractionation. Blood Plasma plays a major role in the osmotic and electrolytic balance which helps in the prevention of blood related disorders. Blood plasma is the composition of water along with various components such as glucose, dissolved proteins, electrolytes, hormones and immunoglobulins. The demand for plasma-derived products is growing along with the rising patient population. The inadequacy of the alternative treatment is providing opportunities to the vendors.

Blood plasma is crucial for keeping the body's blood pressure in check and for maintaining homeostasis. It also delivers multiple hormones and proteins to various sections of the body and aids in blood coagulation and disease prevention. It is mostly water (up to 95 percent by volume) with important dissolved proteins (68%) (e.g., serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3, Cl, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation), and oxygen. Blood plasma's benefits, such as clotting, defense, nutrition, managing acid-base balance, maintaining osmotic pressure, respiration, excretion, and controlling body temperature, are also expected to drive market expansion. Moreover, the market is expected to be fueled by an increase in plasma collection facilities, developments in this area, and acceptance of blood plasma-derived products throughout the estimated period.

Blood Plasma Products Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9%

Largest Market

North America

Fastest Growing Market

Europe

Blood Plasma Products Market Dynamics

Increase in the prevalence of blood disorders is the major factor anticipated to drive the growth of the market. According to the World Federation of Hemophilia, the number of people suffering from blood disorders are 304,362. The government initiatives and support from the non-profit organizations adding the growth of the market. The awareness programs conducted by various government and private organizations to support blood donation, which would meet the growing demand of plasma is enhancing the growth of the market. The age-related issues in the aging population is also likely to enrich the growth of the market over the forecast period. However, the high cost involved in the treatment is likely to hinder the growth of the market. The stringent regulation on the import and export of plasma products is also expected to hamper the growth of the market.

Blood Plasma Products Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

9%

By Product Type

  • Albumin
  • Fresh Frozen Plasma (FFP)
  • Immunoglobulin
  • Protease inhibitors
  • Others

By Application

  • Hematology
  • Hemato-oncology
  • Immunology
  • Rheumatology
  • Others

By End User

  • Hospitals
  • Clinical Research Laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East Africa

Key Features of the Report

  • The blood plasma products market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

Frequently Asked Questions

The blood plasma products market size was valued at US$ x million in 2023 and is set to grow at a significant CAGR of 9% from 2024-2030.

The market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

The market key players are China Biologic Products (China), Grifols (Spain), Shire (Ireland), Kedrion (Italy), Octapharma (Switzerland), Shanghai RAAS, Blood Products (China), CSL (Australia), Bio Product Laboratory (UK)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Blood Plasma Products Market Introduction 
2.1.Global Blood Plasma Products Market  - Taxonomy
2.2.Global Blood Plasma Products Market  - Definitions
2.2.1.Product Type 
2.2.2.Application
2.2.3.End Users
2.2.4.Region
3. Global Blood Plasma Products Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Global Blood Plasma Products Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Global Blood Plasma Products Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Albumin
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Fresh Frozen Plasma (FFP)
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Immunoglobulin
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Protease inhibitors
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
6. Global Blood Plasma Products Market  By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Hematology
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Hemato-oncology
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Immunology
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Rheumatology
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Global Blood Plasma Products Market  By End Users, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Hospitals
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Clinical Research Laboratories
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Others
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Global Blood Plasma Products Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9. North America Blood Plasma Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Product Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Albumin
9.1.2.Fresh Frozen Plasma (FFP)
9.1.3.Immunoglobulin
9.1.4.Protease inhibitors
9.1.5.Others
9.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hematology
9.2.2.Hemato-oncology
9.2.3.Immunology
9.2.4.Rheumatology
9.2.5.Others
9.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals
9.3.2.Clinical Research Laboratories
9.3.3.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10. Europe Blood Plasma Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Albumin
10.1.2.Fresh Frozen Plasma (FFP)
10.1.3.Immunoglobulin
10.1.4.Protease inhibitors
10.1.5.Others
10.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hematology
10.2.2.Hemato-oncology
10.2.3.Immunology
10.2.4.Rheumatology
10.2.5.Others
10.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals
10.3.2.Clinical Research Laboratories
10.3.3.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11. Asia Pacific (APAC) Blood Plasma Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Albumin
11.1.2.Fresh Frozen Plasma (FFP)
11.1.3.Immunoglobulin
11.1.4.Protease inhibitors
11.1.5.Others
11.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hematology
11.2.2.Hemato-oncology
11.2.3.Immunology
11.2.4.Rheumatology
11.2.5.Others
11.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals
11.3.2.Clinical Research Laboratories
11.3.3.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12. Middle East and Africa (MEA) Blood Plasma Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Albumin
12.1.2.Fresh Frozen Plasma (FFP)
12.1.3.Immunoglobulin
12.1.4.Protease inhibitors
12.1.5.Others
12.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hematology
12.2.2.Hemato-oncology
12.2.3.Immunology
12.2.4.Rheumatology
12.2.5.Others
12.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals
12.3.2.Clinical Research Laboratories
12.3.3.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13. Latin America Blood Plasma Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Product Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Albumin
13.1.2.Fresh Frozen Plasma (FFP)
13.1.3.Immunoglobulin
13.1.4.Protease inhibitors
13.1.5.Others
13.2.  Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Hematology
13.2.2.Hemato-oncology
13.2.3.Immunology
13.2.4.Rheumatology
13.2.5.Others
13.3.  End Users Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals
13.3.2.Clinical Research Laboratories
13.3.3.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.China Biologic Products (China)
14.2.2.Grifols (Spain)
14.2.3.Shire (Ireland)
14.2.4.Kedrion (Italy)
14.2.5.Octapharma (Switzerland)
14.2.6.Shanghai RAAS Blood Products (China)
14.2.7.CSL (Australia)
14.2.8.Bio Product Laboratory (UK)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • China Biologic Products (China)
  • Grifols (Spain)
  • Shire (Ireland)
  • Kedrion (Italy)
  • Octapharma (Switzerland)
  • Shanghai RAAS Blood Products (China)
  • CSL (Australia)
  • Bio Product Laboratory (UK)

Related Industry Reports